How Long Can We Live and What Do We Know About the Aging Process?: An Interview with Longevity Expert S. Mitchell Harman, M.D., Ph.D.
Newman, Isadore; Newman, Carole; McNally, Christopher (2001-12)
Cardiac Rehabilitation Intervention and Quality of Life Indicators: A Validation Estimate of Ware's Model
Laux, John M.; Newman, Isadore; Queener, John; Rosneck, Jim; Josephson, Richard (2005-09)
The present study tests Ware’s (1987, 1990) prediction that patient evaluations of quality of life (QOL) are related to physical ability. QOL data from 302 patients were collected prior to initiation and upon completion ...
Administration of a Glycoprotein IIb/IIIa Receptor Blocker with a Thienopyridine Derivative Does Not Increase the Risk of Thrombocytopenia
Silver, Kevin H.; Newman, Isadore; Rohr, Susan M.; Johnson, Jeremy; Josephson, Richard A. (2005-09)
The combination of aspirin, a thienopyridine derivative, and a glycoprotein IIb/IIIa receptor inhibitor has become standard therapy for patients undergoing percutaneous coronary intervention (PCI). Recent studies have ...
Isolated LAD Revascularization in the Modern Era: Demographics and Preliminary Outcomes
Manneh, Arene; Newman, Isadore; Gross, Ann; Syron, Ed; Josephson, Richard (2000-04)
Revascularization of the left anterior descending coronary artery is an important, evolving and controversial topic. There are differences in patient selection, hospital stay and readmission, and hospital cost.